How big is the Drug Discovery Market?

The Drug Discovery Market size is expected to reach USD 100.10 billion in 2024 and grow at a CAGR of 6.59% to reach USD 137.72 billion by 2029. Read More

What is the current Drug Discovery Market size?

In 2024, the Drug Discovery Market size is expected to reach USD 100.10 billion. Read More

Who are the key players in Drug Discovery Market?

Eli Lilly and Company, Bristol-Myers Squibb Company, Novartis AG, Bayer AG and AbbVie Inc. are the major companies operating in the Drug Discovery Market. Read More

Which is the fastest growing region in Drug Discovery Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Drug Discovery Market?

In 2024, the North America accounts for the largest market share in Drug Discovery Market. Read More

What years does this Drug Discovery Market cover, and what was the market size in 2023?

In 2023, the Drug Discovery Market size was estimated at USD 93.50 billion. The report covers the Drug Discovery Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Drug Discovery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key factors driving the Drug Discovery Market?

The Drug Discovery Market is driven by a) The increasing adoption of biologics b) The development of novel drug molecules. Read More

Drug Discovery Market Share

Statistics for the 2023 & 2024 Drug Discovery market share, created by Mordor Intelligence™ Industry Reports. Drug Discovery share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Drug Discovery Industry

The drug discovery market is highly competitive and consists of a number of major players. The market players are implementing innovative strategies and adopting artificial intelligence and machine learning in drug discovery to speed up the process. Furthermore, the key market players are entering into strategic partnerships to develop novel drug molecules. Some of the companies in this market include Eli Lilly and Company, Novartis AG, Bayer AG, AbbVie Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Pfizer Inc., and Sanofi.